Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| Hypermethylation of SOX1 and HOXA9 Genes Is Associated with Clinicopathologic Characteristics of Non-Small Cell Lung Cancer Patients. | Curr Issues Mol Biol | 2025 | 40699796 | PubTator, text mining | PubMed |
| High NUP210 mRNA expression and its role in prognosis of acute myeloid leukemia. | Clin Exp Med | 2025 | 40696208 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA dequencing to identify and validate prognostic genes related to T Cell senescence in acute myeloid leukemia. | Front Bioinform | 2025 | 40635996 | PubTator, text mining | PubMed |
| Dysregulation of heterochromatin caused by genomic structural variants may be central to autism spectrum disorder. | Front Mol Neurosci | 2025 | 40612695 | PubTator, text mining | PubMed |
| Circulating cell-free DNA methylation as biomarker for lung cancer detection: a systematic review and meta-analysis of diagnostic studies. | Syst Rev | 2025 | 40457503 | PubTator, text mining | PubMed |
| The transcription factor HOXA9 induces expression of the chromatin modifier SMYD3 to drive leukemogenesis. | J Biol Chem | 2025 | 40451434 | PubTator, text mining | PubMed |
| Unveiling the dynamic drivers: phase separation's pivotal role in stem cell biology and therapeutic potential. | Stem Cell Res Ther | 2025 | 40442783 | PubTator, text mining | PubMed |
| MENIN inhibitor-based therapy in acute leukemia: latest updates from the 2024 ASH annual meeting. | Exp Hematol Oncol | 2025 | 40405313 | PubTator, text mining | PubMed |
| A comprehensive antigen-antibody complex database unlocking insights into interaction interface. | Elife | 2025 | 40402563 | PubTator, text mining | PubMed |
| Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | 40369674 | PubTator, text mining | PubMed |
| HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling. | Anticancer Res | 2025 | 40295061 | PubTator, text mining | PubMed |
| Site-Specific Expression of HOXA Genes in Skin and its Effect on Skin Elasticity. | J Invest Dermatol | 2025 | 40268230 | PubTator, text mining | PubMed |
| Detecting plasma SHOX2, HOXA9, SEPTIN9, and RASSF1A methylation and circulating cancer cells for cholangiocarcinoma clinical diagnosis and monitoring. | World J Gastrointest Oncol | 2025 | 40235897 | PubTator, text mining | PubMed |
| Inflammatory signaling pathways play a role in SYK inhibitor resistant AML. | Sci Rep | 2025 | 40188268 | PubTator, text mining | PubMed |
| A versatile toolbox for determining IRES activity in cells and embryonic tissues. | EMBO J | 2025 | 40082722 | PubTator, text mining | PubMed |
| Exploring the potential of cell-free tumor DNA in bronchoscopic diagnosis of peripheral lung lesions-the DRILL study. | Eur Clin Respir J | 2025 | 40070531 | PubTator, text mining | PubMed |
| Predictive biomarkers for the efficacy of PARP inhibitors in ovarian cancer: an updated systematic review. | BJC Rep | 2025 | 40069561 | PubTator, text mining | PubMed |
| The HOX code of human adult fibroblasts reflects their ectomesenchymal or mesodermal origin. | Histochem Cell Biol | 2025 | 40063181 | PubTator, text mining | PubMed |
| Variability in expression of homeobox genes (HOXA9) and (HOXA7) in acute myeloid leukemia patients. | Curr Res Transl Med | 2025 | 40058172 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=6